Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 201 through 210 of 424 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Impact of Frailty and Sarcopenia on Post-COVID Recovery

Afilalo, Jonathan | CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General | Operating Grant | $470,179

CIHR Quebec 2021

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

Hobman, Tom C | University of Alberta | Operating Grant | $499,130

CIHR Alberta 2021

Developing and evaluating an online intervention to improve the uptake and maintenance of protective behaviours against COVID‑19 among young adults in Canada

Campbell, Tavis S | The University of Calgary | Project Grant | $271,575

CIHR Alberta 2021

COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs

Lachowsky, Nathan J | University of Victoria | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Network – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Babu, Mohan | The University of Regina | Operating Grant | $100,000

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection

Mui, Alice L | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Discovery of small molecules targeting SARS-CoV-2 frameshifting using a rapid yeast platform

Jan, Eric | University of British Columbia | Project Grant | $445,230

CIHR British Columbia 2021

Upstream determinants of effective COVID‑19 response: tools development and application through a case study in British Columbia

Berman, Peter | University of British Columbia | Project Grant | $118,575

CIHR British Columbia 2021

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Richard, Stéphane | Lady Davis Institute for Medical Research | Operating Grant | $309,250

CIHR Quebec 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Impact of Frailty and Sarcopenia on Post-COVID Recovery

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

Developing and evaluating an online intervention to improve the uptake and maintenance of protective behaviours against COVID‑19 among young adults in Canada

COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs

COVID-19 Variant Network – Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

COVID-19 Variant Supplement – The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection

Discovery of small molecules targeting SARS-CoV-2 frameshifting using a rapid yeast platform

Upstream determinants of effective COVID‑19 response: tools development and application through a case study in British Columbia

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.